HomeInsightsStock Comparison

Balaxi Pharmaceuticals Ltd vs Bharat Parenterals Ltd Stock Comparison

Balaxi Pharmaceuticals Ltd vs Bharat Parenterals Ltd Stock Comparison

Last Updated on: Jul 19, 2025

Key Highlights

  • The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 49.01 as of 18 Jul 15:30.
  • The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 12.1 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Bharat Parenterals Ltd changed from 3.4 on March 2020 to 45 on March 2024 . This represents a CAGR of 67.63% over 5 years.
  • The Market Cap of Balaxi Pharmaceuticals Ltd changed from ₹ 74 crore on March 2020 to ₹ 2702 crore on March 2024 . This represents a CAGR of 105.35% over 5 yearsThe Market Cap of Bharat Parenterals Ltd changed from ₹ 81.25 crore on March 2020 to ₹ 653.08 crore on March 2024 . This represents a CAGR of 51.72% over 5 years.
  • The revenue of Balaxi Pharmaceuticals Ltd for the Mar '25 is ₹ 74.57 crore as compare to the Dec '24 revenue of ₹ 77.23 crore. This represent the decline of -3.44% The revenue of Bharat Parenterals Ltd for the Mar '25 is ₹ 105.91 crore as compare to the Dec '24 revenue of ₹ 75.2 crore. This represent the growth of 40.84%.
  • The ebitda of Balaxi Pharmaceuticals Ltd for the Mar '25 is ₹ 10.86 crore as compare to the Dec '24 ebitda of ₹ 7.93 crore. This represent the growth of 36.95% The ebitda of Bharat Parenterals Ltd for the Mar '25 is ₹ 4.16 crore as compare to the Dec '24 ebitda of ₹ 6.59 crore. This represent the decline of -36.87%.
  • The net profit of Balaxi Pharmaceuticals Ltd changed from ₹ -41.34 crore to ₹ 8.64 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Bharat Parenterals Ltd changed from ₹ 7.01 crore to ₹ -9.44 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Balaxi Pharmaceuticals Ltd changed from 3.41 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Bharat Parenterals Ltd changed from 1.78 % on March 2023 to 2.58 % on March 2024 . This represents a CAGR of 20.39% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Balaxi Pharmaceuticals Ltd

  • Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
  • The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

About Bharat Parenterals Ltd

  • Bharat Parenterals Ltd. was incorporated on Sep.'92 in Gujarat and promoted by Ramesh Desai and Bharat Desai.
  • The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda.
  • It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics. In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016.
  • Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020.
  • Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.

Balaxi Pharmaceuticals Ltd News Hub

News

Balaxi Pharmaceuticals AGM scheduled

Balaxi Pharmaceuticals announced that the 82th Annual General Meeting(AGM) of the company ...

Read more

02 Jun 2025 10:41

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

22 May 2025 19:48

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

03 Feb 2025 10:51

News

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 N...

Read more

30 Oct 2024 16:58

News

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company ...

Read more

01 Aug 2024 12:52

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 A...

Read more

26 Jul 2024 10:45

Bharat Parenterals Ltd News Hub

News

Board of Bharat Parenterals recommends Final Dividend

Bharat Parenterals announced that the Board of Directors of the Company at its meeting hel...

Read more

12 May 2025 17:16

News

Bharat Parenterals to convene board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 12 May ...

Read more

06 May 2025 11:30

News

Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 3 Febru...

Read more

24 Jan 2025 10:28

News

Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 29 Octo...

Read more

21 Oct 2024 10:22

News

Bharat Parenterals announces board meeting date

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 8 Augus...

Read more

01 Aug 2024 10:54

News

Bharat Parenterals schedules AGM

Bharat Parenterals announced that the Annual General Meeting (AGM) of the company will be ...

Read more

12 Jun 2024 10:01

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Bharat Parenterals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Balaxi Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bharat Parenterals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Balaxi Pharmaceuticals Ltd and Bharat Parenterals Ltd

Which company has a larger market capitalization, Balaxi Pharmaceuticals Ltd or Bharat Parenterals Ltd?

Market cap of Balaxi Pharmaceuticals Ltd is 270 Cr while Market cap of Bharat Parenterals Ltd is 1,086 Cr

What are the key factors driving the stock performance of Balaxi Pharmaceuticals Ltd and Bharat Parenterals Ltd?

The stock performance of Balaxi Pharmaceuticals Ltd and Bharat Parenterals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Balaxi Pharmaceuticals Ltd and Bharat Parenterals Ltd?

As of July 19, 2025, the Balaxi Pharmaceuticals Ltd stock price is INR ₹49.01. On the other hand, Bharat Parenterals Ltd stock price is INR ₹1576.25.

How do dividend payouts of Balaxi Pharmaceuticals Ltd and Bharat Parenterals Ltd compare?

To compare the dividend payouts of Balaxi Pharmaceuticals Ltd and Bharat Parenterals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions